$NVIV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INVIVO THERAPEUTICS HOLDINGS CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INVIVO THERAPEUTICS HOLDINGS CORP.. Get notifications about new insider transactions in INVIVO THERAPEUTICS HOLDINGS CORP. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 1.66 | 500 | 830 | 14,373,410 | 14.4 M to 14.4 M (0.00 %) |
| Dec 10 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 1.65 | 3,750 | 6,188 | 14,373,910 | 14.4 M to 14.4 M (-0.03 %) |
| Dec 03 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Option Exercise | A | 1.50 | 600,000 | 900,000 | 600,000 | |
| Oct 31 2012 | NVIV | INVIVO THERAPEUTIC ... | HESS BRIAN | Chief Technology Of ... | Option Exercise | A | 1.69 | 200,000 | 338,000 | 200,000 | |
| Jul 02 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.39 | 20,220 | 48,265 | 7,697,113 | 7.7 M to 7.7 M (-0.26 %) |
| Jul 02 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.31 | 24,780 | 57,167 | 7,717,333 | 7.7 M to 7.7 M (-0.32 %) |
| Jun 28 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.30 | 15,000 | 34,560 | 7,742,113 | 7.8 M to 7.7 M (-0.19 %) |
| Jun 28 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.40 | 13,450 | 32,280 | 7,757,113 | 7.8 M to 7.8 M (-0.17 %) |
| Jun 28 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.42 | 126,550 | 306,251 | 7,770,563 | 7.9 M to 7.8 M (-1.60 %) |
| Apr 17 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.40 | 159,840 | 383,616 | 7,897,113 | 8.1 M to 7.9 M (-1.98 %) |
| Apr 17 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.39 | 40,160 | 95,982 | 8,056,953 | 8.1 M to 8.1 M (-0.50 %) |
| Apr 11 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.21 | 105,000 | 232,523 | 14,377,660 | 14.5 M to 14.4 M (-0.73 %) |
| Apr 11 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.29 | 165,000 | 378,345 | 14,482,660 | 14.6 M to 14.5 M (-1.13 %) |
| Mar 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Option Exercise | A | 2.68 | 590,000 | 1,581,200 | 590,000 | |
| Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.53 | 96,503 | 244,375 | 14,647,660 | 14.7 M to 14.6 M (-0.65 %) |
| Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.63 | 109,000 | 286,779 | 14,744,163 | 14.9 M to 14.7 M (-0.73 %) |
| Jan 06 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.62 | 44,497 | 116,791 | 14,853,163 | 14.9 M to 14.9 M (-0.30 %) |
| Jan 03 2012 | NVIV | INVIVO THERAPEUTIC ... | LANGER ROBERT | 10% Owner | Sell | S | 2.49 | 165,247 | 411,300 | 8,097,113 | 8.3 M to 8.1 M (-2.00 %) |
| Jan 03 2012 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.70 | 11,500 | 31,050 | 14,897,660 | 14.9 M to 14.9 M (-0.08 %) |
| Dec 30 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.52 | 95,000 | 239,020 | 14,909,160 | 15 M to 14.9 M (-0.63 %) |
| Dec 30 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Sell | S | 2.74 | 143,500 | 392,645 | 15,004,160 | 15.1 M to 15 M (-0.95 %) |
| Dec 23 2011 | NVIV | INVIVO THERAPEUTIC ... | STERN ADAM K | Director | Option Exercise | J | 1.40 | 627,901 | 879,061 | 627,901 | |
| Dec 23 2011 | NVIV | INVIVO THERAPEUTIC ... | STERN ADAM K | Director | Option Exercise | J | 1.00 | 577,901 | 577,901 | 577,901 | |
| Dec 12 2011 | NVIV | INVIVO THERAPEUTIC ... | STERN ADAM K | Director | Option Exercise | A | 1.98 | 50,000 | 99,000 | 50,000 | |
| Dec 12 2011 | NVIV | INVIVO THERAPEUTIC ... | NOLEN GEORGE | Director | Option Exercise | A | 1.98 | 50,000 | 99,000 | 50,000 | |
| Dec 12 2011 | NVIV | INVIVO THERAPEUTIC ... | PEDRA CHRISTI | Director | Option Exercise | A | 1.98 | 50,000 | 99,000 | 50,000 | |
| Dec 12 2011 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 1.98 | 50,000 | 99,000 | 50,000 | |
| Dec 07 2011 | NVIV | INVIVO THERAPEUTIC ... | Wirth Edward | Chief Science Offic ... | Option Exercise | A | 1.87 | 775,000 | 1,449,250 | 775,000 | |
| Mar 17 2011 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | CEO, CFO | Option Exercise | A | 1.20 | 250,000 | 300,000 | 250,000 | |
| Dec 14 2010 | NVIV | INVIVO THERAPEUTIC ... | ROBERTS RICHARD JOHN | Director | Option Exercise | A | 2.26 | 50,000 | 113,000 | 50,000 | |
| Dec 14 2010 | NVIV | INVIVO THERAPEUTIC ... | STERN ADAM K | Director | Option Exercise | A | 2.26 | 50,000 | 113,000 | 50,000 | |
| Dec 14 2010 | NVIV | INVIVO THERAPEUTIC ... | PEDRA CHRISTI | Director | Option Exercise | A | 2.26 | 50,000 | 113,000 | 50,000 | |
| Dec 14 2010 | NVIV | INVIVO THERAPEUTIC ... | NOLEN GEORGE | Director | Option Exercise | A | 2.26 | 50,000 | 113,000 | 50,000 | |
| Dec 07 2010 | NVIV | INVIVO THERAPEUTIC ... | KIMBERLIN KEVIN | 10% Owner | Option Exercise | J | 1.40 | 187,331 | 262,263 | 187,331 | |
| Dec 07 2010 | NVIV | INVIVO THERAPEUTIC ... | KIMBERLIN KEVIN | 10% Owner | Option Exercise | J | 1.00 | 187,331 | 187,331 | 187,331 | |
| Dec 07 2010 | NVIV | INVIVO THERAPEUTIC ... | KIMBERLIN KEVIN | 10% Owner | Option Exercise | J | 1.40 | 309,850 | 433,790 | 309,850 | |
| Dec 07 2010 | NVIV | INVIVO THERAPEUTIC ... | KIMBERLIN KEVIN | 10% Owner | Option Exercise | J | 1.00 | 309,850 | 309,850 | 309,850 | |
| Jun 17 2009 | NVIV | INVIVO THERAPEUTIC ... | Reichard Peter | Chief Executive Off ... | Grant | A | 0.00 | 3,275,000 | 0 | 3,275,000 | 0 to 3.3 M |